Pancreatic Cancer Research

ResearcherNantong UniversityNo recent work listed

Xiaorong Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6120-7318; OpenAlex author ID A5009868338. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 4

  1. The low-complexity domains of the KMT2D protein regulate histone monomethylation transcription to facilitate pancreatic cancer progression. Co-author DOI 10.1186/s11658-021-00292-7↗
  2. Triptolide suppresses proliferation, hypoxia-inducible factor-1α and c-Myc expression in pancreatic cancer cells. First author DOI 10.3892/mmr.2015.3960↗
  3. Research on the epigenetic modification of pancreatic cancer vaccine. Last author PMID 24901123↗
  4. Enhancing antitumor effects in pancreatic cancer cells by combined use of COX-2 and 5-LOX inhibitors. Co-author DOI 10.1016/j.biopha.2011.06.009↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaoling Ding · 3 shared papers, 2011–2015 · strength 0.15
  2. Erhao Zhang · 1 shared paper, 2021 · strength 0.13
  3. Weihan Li · 1 shared paper, 2021 · strength 0.13
  4. Guo-Xiong Zhou · 2 shared papers, 2011–2014 · strength 0.08
  5. Bo Jiang · 1 shared paper, 2015 · strength 0.06
  6. Guoxiong Zhou · 1 shared paper, 2015 · strength 0.06
  7. Wei Cao · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.